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Hydrin 2 (vasotocinyl-Gly), ahydroosmotic peptide resulting from differential processing of provasotocin and recently identified in frog neurohypo- 
physis, has been looked for in the pituitary gland of an exotic toad (Bufo marinus) and of a reptile (Vipera arpis). Hydrin 2 has been found in 
the amphibian but not in the reptile. This result confirms the evolutionary specificity of hydrin 2 that has been identified only in frogs and toads 
but not in birds and reptiles. Occurrence of hydrin 2 is explained by its regulatory function on the water permeability of the skin of anurans. 
Hydrin; Neuropeptide; Provasotocin maturation; Differential processing; Neurohypophysial hormone; Bufo marinus; Vipera aspis 
1. INTRODUCTION 
Hydrins are neurohypophysial peptides discovered in 
amphibians and endowed with hydroosmotic activity 
on the skin and the urinary bladder of these animals 
[ 1,2]. They are physiologically produced by partial pro- 
cessing of the vasotocin-neurophysin precursor and 
have been found so far in anurans but not in birds such 
as geese [3]. Hydrin 1 (vasotocinyl-Gly-Lys-Arg) has 
been characterized in the aquatic Xenopus laevis 
(Pipidae) whereas hydrin 2 (vasotocinyl-Gly) has been 
identified in semi-aquatic or terrestrial anuran species 
such as Rana esculenta (Ranidae) [1,2]. Bufo marinus 
is an exotic toad imported on the American continent 
and it is of interest to assess whether hydrin 2 is also 
present in this animal despite its peculiar origin and 
habitat. On the other hand, because hydrins have been 
assumed to result from an adaptative processing proper 
to amphibians for facing a particular osmoregulation 
[1,2], we have examined a reptile, the viper (Vipera 
aspis) in order to check their absence in this class of 
vertebrates. 
been made with 0.2 ml 0.1 M HCl(4’C, 4 h with stirring). After cen- 
trifugation, the pellet is taken in 0.2 ml 0.1 M HCl, centrifuged, and 
the second supernatant, filtered on Millex GV4 Millipore, is added to 
the first. The filter is washed with 0.1 ml 0.1 M HCl and the washing 
added so that a final volume of 0.45 ml has been recovered and sub- 
jected to HPLC. 
A Delta Pak C 18 column (3.9 x 140 mm, particle size 5 pm) has 
been used with a linear acetonitrile gradient (O-60%) containing 
0.05% trifluoroacetic acid applied for 60 min (flow rate: 
0.7 ml/min). Absorbance is monitored at 214 nm. Fractions of 
0.5 ml have been collected in polypropylene tubes (Starsted) and 
stored frozen after addition of 0.02% Tween 20. Two experiments 
have been made with 30 ~1 and 420 pl of the hydrochloric acid extract 
of the posterior pituitary gland. 
2.2. Vipera aspis pituitary extracts 
Viperu aspis hypophyses have been removed in the laboratory less 
than 2 h after decapitation of the animals. They have been desiccated 
in pure acetone for 8 days at 0°C then ground for giving a powder 
[4]. Acetone powder (0.285 mg, corresponding to two entire 
pituitaries) has been extracted by 0.1 M HCl (0.15 ml). From the 
supernatant after centrifugation, 10 ,ui have been taken for bioassays 
and two experiments with 60 and 70~1 have been performed on 
HPLC under the conditions described above. 
3. RESULTS AND DISCUSSION 
2. MATERIALS AND METHODS 
2.1. Bufo marinus pituitary extracts 
Bufo marinus pituitaries have been taken out by Dr Dores. They 
have been placed in cold and peroxide-free acetone immediately after 
removal from the animals. A dried pituitary gland (1.1 mg) has been 
dissected into posterior and anterior parts and extraction of each has 
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Fig. 1 shows separation of Bufo marinus 
neurohypophysial peptides by HPLC. Vasotocin has a 
retention time of 23.20 min and hydrin 2 a retention 
time of 23.40 min. The glycine extension present in 
hydrin 2 with regard to vasotocin and the C-terminal 
carboxyl group instead of the carboxamide group 
found in the latter make the molecule slightly less 
polar. Synthetic vasotocin and hydrin 2, subjected to 
HPLC under similar conditions, have retention times 
of 22.15 and 22.35 min, respectively (Fig. 2). In the 
case of Rana esculenta, the retention times found for 
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Fig. 1. Separation of Bufo marinus neurohypophysial hormones by 
HPLC (details in the text). 
chemically identified vasotocin and hydrin 2, using a 
linear acetonitrile gradient 5-60% [I], were 20.95 and 
21.30 min, respectively, so that the relative positions 
were virtually the same. In the same way, the amount 
of hydrin 2 detected in B. marinus is somewhat higher 
than that of vasotocin, as found for R. escufenta either 
in neurointermediate pituitary extracts [l] or in 
neurosecretory granules [2]. 
Mesotocin is detected with a retention time 
27.40 min compared with 26.30 for the synthetic pep- 
tide and 26.05 for R. escuienta mesotocin in the 
acetonitrile gradient 5-60% [l]. Mesotocin is more 
hydrophobic than vasotocin and hydrin 2 because of 
the presence of an isoleucine in position 8 instead of an 
arginine. 
In the viper, only vasotocin and mesotocin are 
detected with retention times 24.0 and 28.5 min, 
respectively. No trace of hydrin 1 or 2 can be detected 
(Fig. 3). The chromatographic profile resembles the 
one found for goose neurohypophysial peptides [3]. 
Among tetrapods, only amphibians eem to be endow- 
ed with hydrins, these peptides being absent in birds 
and reptiles. 
Hydrin 2 has been detected by HPLC in several 
Ranidae (such as R. esculenta, R. temporaria, R. pi- 
piens) but not in the permanently freshwater-dwelling 
Xenopus laevis in which hydrin 1 (vasotocinyl-Gly-Lys- 
Arg) is found along with vasotocin [l]. Hydrin 1 is ap- 
proximately as active as hydrin 2 on the water 
permeability of the frog skin measured in vivo [5] and 
of the frog urinary bladder in vitro [6]. Xenopus skin 
and bladder have, however, been reported to be not 
sensitive to vasotocin and their derivatives [7]. Ap- 
parently adaptation has acted both on prohormone 
processing and receptor sensitivity. 
The down-regulation of provasotocin processing im- 
plies a decreased activity of the granule carboxypep- 
tidase P-like enzyme (carboxypeptidase H or E) [8-lo] 
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Fig. 2. Separation of synthetic vasotocin, hydrin 2 and mesotocin by 
HPLC (conditions similar to those used for Bufo marinus 
neurohypophysial hormones). 
in the case of hydrin 1, and of the a-amidating enzyme 
(peptidyl-glycine cu-monooxygenase) in the case of 
hydrin 2 [ 11,121. The successive actions of an endopep- 
tidase with specificity for a pair of basic residues, a car- 
boxypeptidase &like enzyme, and the a-amidating 
enzyme are usually complete in non-amphibian 
vertebrates o that only cu-amidated nonapeptide hor- 
mones are found, C-terminally extended intermediates 
being very rarely detected [131. The down-regulation of 
these processing enzymes could be performed in the 
secretory neuron by decreasing enzyme biosynthesis or 
by synthesizing specific inhibitors. In the case of 
anurans, differential processing of the same precursor 
has allowed to manufacture two hormones, apparently 
acting on different osmoregulatory target cells (hydrin 
2 on skin and vasotocin on kidney). The relative pro- 
portions of hydrin 2 and vasotocin are similar in all 
anurans investigated so that processing regulation does 
not seem to depend upon particular species or habitat. 
It is not known whether the two peptides are present in 
distinct neurons or in different granules of the same 
neuron. Neurons producing mesotocin in the same 
animal are not subjected to the down-regulated pro- 
cessing since extended intermediates are not detected. 
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Fig. 3. Separation of Vipera aspis neurohypophysial hormones by 
HPLC (details in the text). 
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The water permeability of the skin and of the urinary 
bladder is specific to amphibians and related to their 
evolutionary adaptation to terrestrial conditions. It 
would be of interest to investigate differential process- 
ing for other prohormones in respect o differentiation 
and adaptation. Differential processing of pro- 
opiomelanocortin has been observed, this precursor be- 
ing processed into corticotropin (39 residues) in cor- 
ticotropic cells of the anterior pituitary gland and 
a-melanocyte stimulating hormone (13 residues) in 
melanotropic cells of the intermediate lobe [14]. 
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